Stephens Inc Boston Scientific Corp Transaction History

Stephens Inc

$6.2 Billion
Q1 2024

A detailed history of Stephens Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Stephens Inc holds 9,648 shares of BSX stock, worth $734,309. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,648

Previous 9,658 0.1%

Holding current value

$734,309

Previous $558,000 18.28%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $576 - $686	-10 Reduced 0.1%	9,648 $660,000
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $1.53 Million - $1.82 Million	-31,481 Reduced 76.52%	9,658 $558,000
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $100,982 - $110,016	2,012 Added 5.14%	41,139 $2.17 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $1.39 Million - $1.53 Million	-27,979 Reduced 41.69%	39,127 $2.12 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $851,344 - $944,616	18,881 Added 39.15%	67,106 $3.36 Million

Q4 2022 Jan 25, 2023	BUY	$39.56 - $47.22 $1.49 Million - $1.78 Million	37,711 Added 358.67%	48,225 $2.23 Million
Q3 2022 Nov 02, 2022	SELL	$36.71 - $109.66 $17,510 - $52,307	-477 Reduced 4.34%	10,514 $407,000
Q2 2022 Aug 03, 2022	SELL	$35.24 - $47.1 $125,278 - $167,440	-3,555 Reduced 24.44%	10,991 $410,000
Q1 2022 May 04, 2022	SELL	$40.9 - $45.1 $198,651 - $219,050	-4,857 Reduced 25.03%	14,546 $644,000
Q4 2021 Mar 07, 2022	BUY	$38.07 - $44.87 $172,837 - $203,709	4,540 Added 30.55%	19,403 $824,000
Q3 2021 Oct 27, 2021	SELL	$41.23 - $45.88 $64,731 - $72,031	-1,570 Reduced 9.55%	14,863 $645,000
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $33,603 - $38,533	-871 Reduced 5.03%	16,433 $703,000
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $26,417 - $29,712	-749 Reduced 4.15%	17,304 $669,000
Q4 2020 Feb 10, 2021	BUY	$33.15 - $41.97 $165 - $209	5 Added 0.03%	18,053 $649,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $4,546 - $5,574	132 Added 0.74%	18,048 $690,000
Q2 2020 Aug 24, 2020	BUY	$30.19 - $39.11 $114,027 - $147,718	3,777 Added 26.71%	17,916 $629,000
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $2,479 - $4,388	-96 Reduced 0.67%	14,139 $461,000
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $1,893 - $2,268	-50 Reduced 0.35%	14,235 $644,000
Q3 2019 Oct 18, 2019	BUY	$40.31 - $43.45 $77,637 - $83,684	1,926 Added 15.58%	14,285 $581,000
Q2 2019 Aug 01, 2019	SELL	$34.91 - $42.98 $44,091 - $54,283	-1,263 Reduced 9.27%	12,359 $531,000
Q1 2019 May 03, 2019	SELL	$32.91 - $40.75 $277,398 - $343,481	-8,429 Reduced 38.23%	13,622 $523,000
Q4 2018 Feb 11, 2019	SELL	$31.73 - $39.04 $793,345 - $976,117	-25,003 Reduced 53.14%	22,051 $779,000
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $1.54 Million - $1.82 Million	47,054 New	47,054 $1.81 Million

Others Institutions Holding BSX

# of Institutions

1,323

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $109B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account